• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳青霉烯酶生产者在全球范围内肠杆菌科中的难以控制的传播。

The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.

机构信息

Medical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland; Hôpital Fribourgeois - Hôpital Cantonal de Fribourg, Fribourg, Switzerland; INSERM U914, South-Paris Medical School, K.-Bicêtre, France.

出版信息

Clin Microbiol Infect. 2014 Sep;20(9):821-30. doi: 10.1111/1469-0691.12719.

DOI:10.1111/1469-0691.12719
PMID:24930781
Abstract

The spread of carbapenemase producers in Enterobacteriaceae has now been identified worldwide. Three main carbapenemases have been reported; they belong to three classes of β-lactamases, which are KPC, NDM, and OXA-48. The main reservoirs of KPC are Klebsiella pneumoniae in the USA, Israel, Greece, and Italy, those of NDM are K. pneumoniae and Escherichia coli in the Indian subcontinent, and those of OXA-48 are K. pneumoniae and Escherichia coli in North Africa and Turkey. KPC producers have been mostly identified among nosocomial isolates, whereas NDM and OXA-48 producers are both nosocomial and community-acquired pathogens. Control of their spread is still possible in hospital settings, and relies on the use of rapid diagnostic techniques and the strict implemention of hygiene measures.

摘要

目前,肠杆菌科中产碳青霉烯酶的细菌已经在全球范围内被发现。已报告有三种主要的碳青霉烯酶;它们属于三类β-内酰胺酶,分别为 KPC、NDM 和 OXA-48。KPC 的主要储主是美国、以色列、希腊和意大利的肺炎克雷伯菌,NDM 的主要储主是印度次大陆的肺炎克雷伯菌和大肠杆菌,OXA-48 的主要储主是北非和土耳其的肺炎克雷伯菌和大肠杆菌。KPC 的产生产生者主要在医院环境中分离到,而 NDM 和 OXA-48 的产生产生者既存在于医院环境中,也存在于社区获得性感染中。在医院环境中仍然可以控制它们的传播,这依赖于快速诊断技术的使用和严格执行卫生措施。

相似文献

1
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.碳青霉烯酶生产者在全球范围内肠杆菌科中的难以控制的传播。
Clin Microbiol Infect. 2014 Sep;20(9):821-30. doi: 10.1111/1469-0691.12719.
2
Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.德国医院中产碳青霉烯酶大肠杆菌和肺炎克雷伯菌的多中心调查。
Int J Med Microbiol. 2016 Sep;306(6):415-20. doi: 10.1016/j.ijmm.2016.05.009. Epub 2016 May 13.
3
Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals.比利时医院中产碳青霉烯酶大肠埃希菌和肺炎克雷伯菌的发病率不断上升。
Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):139-146. doi: 10.1007/s10096-016-2782-x. Epub 2016 Sep 17.
4
Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.2014-2016 年斯洛文尼亚成功控制首例 OXA-48 和/或 NDM 碳青霉烯酶产生的肺炎克雷伯菌爆发
J Hosp Infect. 2019 Feb;101(2):142-149. doi: 10.1016/j.jhin.2018.10.022. Epub 2018 Nov 3.
5
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.在一家三级护理中心的大肠杆菌和肺炎克雷伯菌血分离株中发现和表型检测 A 类碳青霉烯酶。
J Microbiol Immunol Infect. 2013 Apr;46(2):104-8. doi: 10.1016/j.jmii.2012.01.004. Epub 2012 Apr 26.
6
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.产碳青霉烯酶肺炎克雷伯菌和大肠埃希菌在欧洲产碳青霉烯酶肠杆菌科的调查(EuSCAPE)中的发生:一项前瞻性、多国研究。
Lancet Infect Dis. 2017 Feb;17(2):153-163. doi: 10.1016/S1473-3099(16)30257-2. Epub 2016 Nov 18.
7
Carbapenem resistance in and among Indian and international patients in North India.印度北部印度及国际患者中碳青霉烯类耐药情况。 (你提供的原文似乎不完整,“in and among”表述不太清晰准确,推测完整内容可能是想表达在印度及国际患者群体中的碳青霉烯类耐药情况 )
Acta Microbiol Immunol Hung. 2019 Sep 1;66(3):367-376. doi: 10.1556/030.66.2019.020.
8
Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).捷克医院产碳青霉烯酶大肠埃希菌和肺炎克雷伯菌分离株的患病率研究——欧洲产碳青霉烯酶肠杆菌科细菌调查(EuSCAPE)捷克部分的结果
Epidemiol Mikrobiol Imunol. 2015 Jun;64(2):87-91.
9
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.产 OXA-48 碳青霉烯酶肠杆菌科细菌导致的菌血症:主要临床挑战。
Clin Microbiol Infect. 2013 Feb;19(2):E72-9. doi: 10.1111/1469-0691.12091. Epub 2012 Dec 12.
10
[Carbapenemases in enterobacteriaceae].[肠杆菌科中的碳青霉烯酶]
Arch Pediatr. 2010 Sep;17 Suppl 4:S154-62. doi: 10.1016/S0929-693X(10)70918-0.

引用本文的文献

1
Rapid screening for carbapenemase-producing carbapenem-resistant : clinical implementation of an immunochromatographic test using broth-enriched rectal swabs.产碳青霉烯酶的耐碳青霉烯菌的快速筛查:使用肉汤增菌直肠拭子进行免疫层析试验的临床应用
Microbiol Spectr. 2025 Sep 2;13(9):e0131325. doi: 10.1128/spectrum.01313-25. Epub 2025 Aug 8.
2
Validation of immunochromatographic test in broth-enriched rectal swab specimens.肉汤增菌直肠拭子标本中免疫层析试验的验证
Braz J Infect Dis. 2025 Jun 30;29(5):104559. doi: 10.1016/j.bjid.2025.104559.
3
Differing Rates of Carbapenem Resistance in Gram-Negative Bacteria Within Lower and Higher Socioeconomic Classes in Eastern India.
印度东部社会经济阶层较低和较高地区革兰氏阴性菌对碳青霉烯类抗生素耐药率的差异
Cureus. 2025 May 7;17(5):e83661. doi: 10.7759/cureus.83661. eCollection 2025 May.
4
"Global divide in carbapenem resistance and hypervirulence of Klebsiella pneumonia: comparing trends in India and developed nations"- a comprehensive review.《全球碳青霉烯类耐药与肺炎克雷伯菌高毒力的差异:印度与发达国家趋势比较》——一篇综述
J Antibiot (Tokyo). 2025 Jun 3. doi: 10.1038/s41429-025-00833-8.
5
Epidemiological Characteristics and Carbapenemase Analysis of Carbapenem-Resistant Enterobacterales Isolates in a Teaching Hospital in Guangzhou, China.中国广州某教学医院耐碳青霉烯类肠杆菌科细菌分离株的流行病学特征及碳青霉烯酶分析
Infect Drug Resist. 2025 Apr 25;18:2105-2117. doi: 10.2147/IDR.S507692. eCollection 2025.
6
Antimicrobial resistance and vaccines in Enterobacteriaceae including extraintestinal pathogenic Escherichia coli and Klebsiella pneumoniae.肠杆菌科细菌中的抗菌药物耐药性与疫苗,包括肠外致病性大肠杆菌和肺炎克雷伯菌。
NPJ Antimicrob Resist. 2025 Apr 28;3(1):34. doi: 10.1038/s44259-025-00100-8.
7
Identification of CMY-190, a novel chromosomally encoded AmpC β-lactamase, and plasmid-encoded KPC-2 in a clinical isolate of .在一株临床分离株中鉴定出新型染色体编码的AmpCβ-内酰胺酶CMY-190和质粒编码的KPC-2 。
Front Microbiol. 2025 Feb 17;16:1526882. doi: 10.3389/fmicb.2025.1526882. eCollection 2025.
8
Molecular Characterization of Carbapenem and Colistin Resistance in Isolates Obtained from Clinical Samples at a University Hospital Center in Algeria.阿尔及利亚某大学医院中心临床样本中分离出的碳青霉烯类和黏菌素耐药性的分子特征分析
Microorganisms. 2024 Sep 25;12(10):1942. doi: 10.3390/microorganisms12101942.
9
Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?应对产金属β-内酰胺酶革兰氏阴性菌感染的当前治疗格局:存在哪些局限性?
Infect Dis Ther. 2024 Nov;13(11):2423-2447. doi: 10.1007/s40121-024-01044-8. Epub 2024 Oct 1.
10
Antibiotic resistance of isolates from different water sources in Mbarara, Uganda.乌干达姆巴拉拉不同水源分离株的抗生素耐药性。
J Water Health. 2024 Sep;22(9):1579-1593. doi: 10.2166/wh.2024.319. Epub 2024 Aug 22.